Thrive Wealth Management, LLC Immunity Bio, Inc. Transaction History
Thrive Wealth Management, LLC
- $518 Million
- Q1 2025
A detailed history of Thrive Wealth Management, LLC transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Thrive Wealth Management, LLC holds 10,077 shares of IBRX stock, worth $21,161. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,077Holding current value
$21,161% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding IBRX
# of Institutions
238Shares Held
82.5MCall Options Held
1.02MPut Options Held
2.25M-
Vanguard Group Inc Valley Forge, PA17.3MShares$36.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$24 Million0.0% of portfolio
-
State Street Corp Boston, MA9.79MShares$20.5 Million0.0% of portfolio
-
Morgan Stanley New York, NY4.01MShares$8.41 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.84MShares$8.07 Million0.0% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $841M
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...